From our Annual Public Meeting to topic-specific convenings, the Reagan-Udall Foundation for the FDA brings stakeholders together on matters critical to regulatory science and practice. These events, often hosted at the request of FDA leadership, provide space for expert analysis and candid discussion on FDA’s priority issues. See below for upcoming events.

Upcoming Events

- Join the Food and Drug Administration (FDA) and the Reagan-Udall Foundation for the FDA for the fifth Online Controlled Substances Summit.
The Reagan-Udall Foundation for the FDA, in collaboration with the FDA, is hosting a hybrid public workshop on "Understanding Current Use of Ketamine for Emerging Areas of Therapeutic Interest."

Past Events

The Reagan-Udall Foundation for the FDA, in collaboration with the Food and Drug Administration (FDA), hosted a public webinar as part of a series of webinars for FDA-issued guidance related to real-world evidence (RWE).
The Reagan-Udall Foundation for the FDA, in collaboration with FDA’s Rare Diseases Team within the Office of Rare Diseases, Pediatrics, Urologic and Reproductive Medicine; Office of New Drugs; Center for Drug Evaluation and Research and the National Institutes of Health’s Division of Rare Diseases Research Innovation within the National Center for Advancing Translational Sciences, is hosting a public workshop.
Each year, the Reagan-Udall Foundation for the FDA conducts an annual public meeting to discuss its activities in support of the U.S. Food and Drug Administration.
Qualifying Biomarkers to Support Rare Disease Regulatory Pathways
- Advancing Psychedelic Clinical Study DesignVirtual Public Meeting Day 1: January 31, 2024 | 10am-2pm (eastern)
Front-of-Package Nutrition LabelingVirtual Public Meeting
Integrating Clinical Studies Into Health Care Delivery: Post-Market Evidence Generation for Medical ProductsVirtual Public Meeting
Strategies for Improving Public Understanding of FDA-Regulated Products Virtual Public Meeting
Mitigating Risks from Human Xylazine Exposure Public Meeting: In-person and Virtual